Dr. Karol Sikora Accepts Appointment to MEI Healthcare Group's Board of Directors

CORAL SPRINGS, Florida, July 19, 2011 /PRNewswire/ --

MEI Healthcare Group, a leading provider of healthcare strategies and equipment solutions to medical facilities around the world, announced today that Dr. Karol Sikora has accepted an appointment to the company's board of directors. Sikora is the medical director of CancerPartnersUK, the largest independent cancer network in the UK, and is dean of medicine at the University of Buckingham, Britain's first independent medical school. Sikora was previously Chief of the World Health Organization's cancer programme and served as professor and chairman of the Department of Cancer Medicine at Imperial College School of Medicine. He is currently an honorary consultant oncologist at Hammersmith Hospital in London, where he served as clinical director for cancer services for 12 years, and is a fellow of Corpus Christi College in Cambridge.

"We are delighted to have Professor Sikora as a member of our board. His vision and experience on the international stage in both the public and private sectors will be a major asset to the MEI Healthcare Group," said MEI board chair Dr. Arthur Porter.

While serving at Hammersmith Hospital, Sikora chaired that facility's fundraising campaign, an appeal that raised 8m pounds Sterling to construct the Cancer Centre at Hammersmith.  Later, he became vice president for Pharmacia Corporation and managed the company's global clinical research for oncology. He is currently an adviser to the World Health Organization, the International Atomic Energy Agency (IAEA) and is a member of the UK Health Department's Expert Advisory Group on Cancer.

Sikora has published more than 300 papers and written or edited 20 books including Treatment of Cancer - the standard British postgraduate textbook now in its fifth edition and, most recently, The Economics of Cancer Care.  He is on the editorial board of several journals and is the founding editor of Gene Therapy and Cancer Strategy.

MEI provides business development, capital equipment funding strategies and growth consulting services to physicians, hospitals and healthcare systems worldwide.

About MEI Healthcare Group

Headquartered in Coral Springs, Fla., MEI is a comprehensive healthcare strategy firm that works with physician groups and medical centers to provide turnkey healthcare solutions. MEI and its subsidiaries, MEI Development Corporation, MEI Healthcare Capital, MEI Informatics, MEI Healthcare International and MEI Healthcare Foundation, offer its clients more than 40 years of healthcare business experience and the value-added benefits of its strategic alliances. For more information, visit http://www.mei.com

CONTACT:
Tyler Lecceadone
SeyferthPR
+1-800-435-9539
Lecceadone@seyferthpr.com